XML 49 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
May 03, 2025
Apr. 27, 2024
Cash flows from operating activities:    
Net income (loss) $ (65,825) $ (75,749)
Less: Loss from discontinued operations, net of tax 0 (730)
Loss from continuing operations, net of tax (65,825) (75,019)
Adjustments to reconcile net loss from continuing operations to net cash flows from operating activities from continuing operations:    
Depreciation and amortization expense 37,939 40,560
Impairment loss (non cash) 1,713 7,166
Loss on debt extinguishment 55,233 0
Amortization of deferred financing costs 5,164 13,150
Interest expense (paid-in-kind) 0 2,652
Deferred taxes (829) 125
Stock-based compensation expense 5,386 3,380
Changes in operating lease right-of-use assets and liabilities (4,218) (1,322)
Changes in other long-term assets and liabilities and other, net 7,072 (20,997)
Changes in other operating assets and liabilities, net:    
Receivables, net 761 (6,326)
Merchandise inventories 44,475 (21,058)
Textbook rental inventories 1,876 (704)
Prepaid expenses and other current assets 7,096 31,593
Accounts payable and accrued liabilities (181,256) 25,255
Changes in other operating assets and liabilities, net (127,048) 28,760
Net cash flows used in operating activities from continuing operations (85,413) (1,545)
Net cash flows used in operating activities from discontinued operations 0 (3,577)
Net cash flows used in operating activities (85,413) (5,122)
Cash flows from investing activities:    
Purchases of property and equipment (12,894) (14,070)
Proceeds from the sale of fixed assets 793 78
Net cash flows used in investing activities from continuing operations (12,101) (13,992)
Net cash flows provided by investing activities from discontinued operations 0 21,395
Net cash flows (used in) provided by investing activities (12,101) 7,403
Cash flows from financing activities:    
Proceeds from borrowings 887,055 563,023
Repayments of borrowings (948,920) (552,230)
Payment of deferred financing costs (5,569) (16,316)
Proceeds from Private Equity Investment 50,000 0
Proceeds from Rights Offering 45,000 0
Payment of equity issuance costs (9,914) 0
Principal stockholder expense reimbursement 1,940 0
Payment on principal portion of finance lease (370) 0
Shares sold under at-the-market offering, net of commissions 78,450 0
Purchase of treasury shares (5) (176)
Net cash flows provided by (used in) financing activities 97,667 (5,699)
Net increase (decrease) in cash, cash equivalents, and restricted cash 153 (3,418)
Cash, cash equivalents, and restricted cash at beginning of year 28,570 31,988
Cash, cash equivalents, and restricted cash of continuing operations at end of year 28,723 28,570
Cash paid during the period for:    
Interest paid 17,912 24,943
Income taxes paid (net of refunds) $ 2,130 $ (7,293)